Replies to post #791771 on NorthWest Biotherapeutics Inc (NWBO)

[Red_Right_Hand]

Also, EAGs are subject-matter specific, specialized subcommittee's of the CHM that meet separately from the main CHM. https://www.gov.uk/government/organisations/commission-on-human-medicines/about/membership

The EAG meeting minutes are nowhere near as up-to-date as those of the main committee. https://app.box.com/s/jv487awvqzzsrdql0o34h9gg350ceyd4/folder/2988954641

For example, the Oncology and Haematology EAG (OHEAG) has not updated its minutes since November 2023 https://app.box.com/s/jv487awvqzzsrdql0o34h9gg350ceyd4/folder/2988834619

[maverick_1]

The links to still Top of Mind
GoodGuyBillhttps://t.co/Uht7fMYb6J
Kabunushi https://t.co/LwNH6jOdmq
Henry Muneyhttps://t.co/4aPb1i20eB
Peter Davishttps://t.co/et7qQO2oRL

— maverick_1 (@maveric92283613) October 9, 2025

Cutting thru the Bureaucratic RED TAPE

VS
HABITUAL decade long NWBO EPIC which 99% are GUILTY of

Hyper Focus MYOPIA

Unlikely anyone in this EPIC has had the needed requisites of diverse business experience along with high level WallSt experience to discipher vs that of
a scientific background & staff job.

DIFFERENT STROKES for DIFFERENT FOLKS

[seekinganswers]

You are looking in the wrong place....

"While no public documents explicitly name DCVax-L in EWG (Expert Working Group) minutes (confidential per MHRA policy), its MAA review likely involves EWG consultation, given the therapy's personalised nature and GBM's unmet need.

Challenges and Future Outlook Hurdles: Evidence from external controls debated (vs. randomized trials); high manufacturing costs; scalability for NHS access.

[learningcurve2020]

Have we seen this posted on the MHRA public Freedom of Information Act page or was that just a disciple communication?

>>In fact, an official MHRA communication confirmed “this application has not been in backlog or delayed in assessment.”